Cargando…
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849404/ https://www.ncbi.nlm.nih.gov/pubmed/35187406 http://dx.doi.org/10.1097/HS9.0000000000000688 |
| _version_ | 1784652458061987840 |
|---|---|
| author | Liebers, Nora Schönland, Stefan O. Speer, Claudius Edelmann, Dominic Schnitzler, Paul Kräusslich, Hans-Georg Mueller-Tidow, Carsten Hegenbart, Ute Dietrich, Sascha |
| author_facet | Liebers, Nora Schönland, Stefan O. Speer, Claudius Edelmann, Dominic Schnitzler, Paul Kräusslich, Hans-Georg Mueller-Tidow, Carsten Hegenbart, Ute Dietrich, Sascha |
| author_sort | Liebers, Nora |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8849404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88494042022-02-18 Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis Liebers, Nora Schönland, Stefan O. Speer, Claudius Edelmann, Dominic Schnitzler, Paul Kräusslich, Hans-Georg Mueller-Tidow, Carsten Hegenbart, Ute Dietrich, Sascha Hemasphere Letter Lippincott Williams & Wilkins 2022-02-15 /pmc/articles/PMC8849404/ /pubmed/35187406 http://dx.doi.org/10.1097/HS9.0000000000000688 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter Liebers, Nora Schönland, Stefan O. Speer, Claudius Edelmann, Dominic Schnitzler, Paul Kräusslich, Hans-Georg Mueller-Tidow, Carsten Hegenbart, Ute Dietrich, Sascha Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis |
| title | Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis |
| title_full | Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis |
| title_fullStr | Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis |
| title_full_unstemmed | Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis |
| title_short | Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis |
| title_sort | seroconversion rates after the second covid-19 vaccination in patients with systemic light chain (al) amyloidosis |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849404/ https://www.ncbi.nlm.nih.gov/pubmed/35187406 http://dx.doi.org/10.1097/HS9.0000000000000688 |
| work_keys_str_mv | AT liebersnora seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT schonlandstefano seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT speerclaudius seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT edelmanndominic seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT schnitzlerpaul seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT krausslichhansgeorg seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT muellertidowcarsten seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT hegenbartute seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis AT dietrichsascha seroconversionratesafterthesecondcovid19vaccinationinpatientswithsystemiclightchainalamyloidosis |